• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Ocular myasthenic syndrome, adverse reaction to omalizumab? A case report.眼肌型重症肌无力综合征，奥马珠单抗的不良反应？一例病例报告。
Br J Clin Pharmacol. 2017 Oct;83(10):2330-2332. doi: 10.1111/bcp.13338. Epub 2017 Jun 19.
2
Omalizumab-induced ocular myasthenia gravis?奥马珠单抗诱发的眼肌型重症肌无力？
Can J Ophthalmol. 2024 Oct;59(5):e630-e632. doi: 10.1016/j.jcjo.2024.03.018. Epub 2024 Apr 14.
3
Omalizumab-induced colitis.奥马珠单抗诱发的结肠炎。
Dig Liver Dis. 2021 Oct;53(10):1356-1358. doi: 10.1016/j.dld.2020.08.017. Epub 2020 Sep 4.
4
Prevention of omalizumab-induced headache.预防奥马珠单抗诱发的头痛。
J Paediatr Child Health. 2017 Mar;53(3):318. doi: 10.1111/jpc.13431.
5
Biological therapy-associated adverse reactions in asthma: analysis of reporting to the Portuguese pharmacovigilance system.哮喘的生物治疗相关不良反应：向葡萄牙药物警戒系统报告的分析。
Expert Opin Drug Saf. 2020 Jan;19(1):99-106. doi: 10.1080/14740338.2020.1686481. Epub 2019 Oct 31.
6
Clinical impact of omalizumab treatment in children with severe asthma: Report of a local experience.奥马珠单抗治疗重度哮喘儿童的临床疗效：一项本地经验报告。
Arch Argent Pediatr. 2019 Apr 1;117(2):e115-e120. doi: 10.5546/aap.2019.eng.e115.
7
[Myasthenic syndrome induced by chloroquine poisoning: an unusual clinical form confirmed by ocular involvement].
Bull Soc Ophtalmol Fr. 1984 Feb;84(2):219-22, 225.
8
Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry.奥马珠单抗治疗高合并症发生率的重度过敏性哮喘人群的疗效和应答预测因素：澳大利亚 Xolair 注册研究。
Intern Med J. 2016 Sep;46(9):1054-62. doi: 10.1111/imj.13166.
9
Long-term "real-life" safety of omalizumab in patients with severe uncontrolled asthma: A nine-year study.奥马珠单抗治疗重度未控制哮喘患者的长期“真实世界”安全性：一项九年研究。
Respir Med. 2017 Sep;130:55-60. doi: 10.1016/j.rmed.2017.07.013. Epub 2017 Jul 19.
10
Asthma with multiple allergic comorbidities is associated with complete response to omalizumab.伴有多种过敏性合并症的哮喘与对奥马珠单抗的完全缓解相关。
Clin Exp Allergy. 2019 May;49(5):733-735. doi: 10.1111/cea.13373. Epub 2019 Mar 18.

引用本文的文献

1
Effects of omalizumab therapy on peripheral nerve functions: short observational study.奥马珠单抗治疗对周围神经功能的影响：短期观察性研究
Postepy Dermatol Alergol. 2019 Apr;36(2):211-216. doi: 10.5114/ada.2018.74834. Epub 2018 Apr 3.

本文引用的文献

1
Clinical Characteristics of Patients With Double-Seronegative Myasthenia Gravis and Antibodies to Cortactin.伴有皮质钙蛋白抗体的双重血清阴性重症肌无力患者的临床特征。
JAMA Neurol. 2016 Sep 1;73(9):1099-104. doi: 10.1001/jamaneurol.2016.2032.
2
Myasthenia gravis associated with ipilimumab and nivolumab in the treatment of small cell lung cancer.伊匹木单抗和纳武单抗治疗小细胞肺癌相关的重症肌无力。
Muscle Nerve. 2015 Aug;52(2):307-8. doi: 10.1002/mus.24648. Epub 2015 May 14.
3
A systematic review of drug-induced subacute cutaneous lupus erythematosus.药物诱导的亚急性皮肤型狼疮的系统性综述。
Br J Dermatol. 2011 Mar;164(3):465-72. doi: 10.1111/j.1365-2133.2010.10110.x. Epub 2011 Feb 17.
4
Effects of omalizumab on markers of inflammation in patients with allergic asthma.奥马珠单抗对过敏性哮喘患者炎症标志物的影响。
Allergy. 2009 Dec;64(12):1728-36. doi: 10.1111/j.1398-9995.2009.02201.x. Epub 2009 Oct 15.
5
Asthma.哮喘
N Engl J Med. 2009 Mar 5;360(10):1002-14. doi: 10.1056/NEJMra0804579.
6
Trace level analysis of leached Protein A in bioprocess samples without interference from the large excess of rhMAb IgG.生物工艺样品中浸出的蛋白A的痕量分析，不受大量多余的重组单克隆抗体IgG的干扰。
J Immunol Methods. 2009 Feb 28;341(1-2):59-67. doi: 10.1016/j.jim.2008.10.015. Epub 2008 Nov 27.

Ocular myasthenic syndrome, adverse reaction to omalizumab? A case report.

作者信息

Kalteren Willemien S, Schreurs Marco W J, Jorritsma-Smit Annelies, Touw Daan J, de Jong Jan Willem, Zweers Petra G M A, Reesink Fransje E

机构信息

University of Groningen, University Medical Center Groningen, The Netherlands.

Department of Immunology, Erasmus MC, University Medical Center Rotterdam, The Netherlands.

出版信息

Br J Clin Pharmacol. 2017 Oct;83(10):2330-2332. doi: 10.1111/bcp.13338. Epub 2017 Jun 19.

DOI:10.1111/bcp.13338
PMID:28631271
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5595933/
Abstract
摘要